News & Resources

Engaging Conference Attendees Through Live Meetings

This blog will identify some of the innovative as well as conventional ways you can better engage with conference attendees—including key opinion leaders (KOLs)—by delivering dynamic content during live events.

A medical congress by its nature attracts attendees who are typically self-directed and want to be involved in the learning process. Of course, these attendees are usually quite knowledgeable, so it’s important to engage them in a way that leverages their own experience. Presenting content with clear objectives appeals to goal-oriented meeting participants and can strengthen your position as a partner. Efficiency is key when communicating with your audience at a large-scale conference, so make sure your content is relevant to their work.

A new approach to engaging with conference attendees focuses on smaller groups, creating more-immersive experiences, and live meetings. The conventional lecture format of medical meetings can still be informative; however, attendees are looking for unique and memorable learning experiences and want to be personally engaged. A provider of oncology insights for the life sciences industry offers many programs that can help guide you in live event planning. We will discuss formats that engage with meeting attendees in a face-to-face manner, as well as appropriate content that is energizing and inspiring.

DISCUSSION GROUPS
Discussion groups are organized around a specific topic and can provide an energized perspective to emerging medical practices and treatments. Different approaches to leading a discussion group can help focus the content and benefit the organizer. One approach, called “appreciative inquiry” (AI), describes a discussion group model that asks questions in order to focus on change, assessing, for example, a product or trial design that may be deficient. Two articles on AI from the NIH database discuss the ability of AI to transform healthcare practices and medical education.

“Buzz groups” are smaller groups that break off to generate ideas that can be taken back to a network or shared with colleagues, enabling further discussion or decision-making. The “jigsaw” approach to organizing discussion groups pairs participants with experts to learn a subset of material, which the participants then share with their own professional group or peer network.

DEMONSTRATIONS AND SIMULATIONS
A demonstration or simulated encounter offers a unique perspective and also provides an excellent opportunity to showcase your product. A creative approach may be using models to demonstrate your drug’s mechanism of delivery, or an animated simulation magnifying and articulating the science. Virtual reality is on the forefront of trendy and tech-savvy demonstration techniques; if the technology is accessible to you, this type of demonstration can be leveraged to attract forward-thinking individuals. This is a creative opportunity for your company to establish its brand and product as cutting-edge in treatment options.

MEDIA PRESENTATIONS
Take your presentation from the stage to your booth. You can actively engage an individual or small group with a short animation, sleek infographics, or a dynamic PowerPoint video. This helps focus a private discussion and projects a message that is consistent with your branding story. It is also an opportunity to stand out with a modern and stylish presentation design. You can even email the reference file directly to your private audience. This allows you to pack all your points into an effective and targeted message. Furthermore, media-rich content is money well spent at a large medical conference, because it makes the experience more memorable.

MINI-LECTURES
Mini-lectures can make use of the same media content and allow time for a facilitated discussion. As opposed to a key lecture, a mini-lecture presents scaled-down information to meeting attendees in a more personal setting. This can be an effective means of introducing a product or new treatment option or for testing a specific branding position.

ROUNDTABLE DISCUSSIONS
Whether they center around a breakfast, dinner, or a cocktail event, roundtable discussions are a terrific opportunity to engage a curated or random group of individuals in very interesting conversation. This is a great opportunity to test the waters regarding the introduction of a new innovative technique or treatment modality.

TWEETUPS AND SOCIAL MEDIA GROUPS
You can spark a discussion on social media prior to the conference, to ask a question or provide hints surrounding the content you will be presenting. This is one of the most modern approaches to engaging conference attendees and could initiate a relationship that can be carried on throughout the meeting and sustained after it has ended. This approach to conducting live interactions also has the potential to be tailored to the real-time feedback you receive during the course of the conference. Invitations via Twitter or Facebook, for example, are attractive to many meeting attendees. These so-called “tweetups” are like post-conference happy hours; attendees can carry on the conversation after hours or fulfill their networking goals.

In summary, live events are used to initiate more-intimate relationships with meeting attendees, provide a more casual environment for sharing ideas, and strengthen existing partnerships. Discussion groups can focus on actual change, inviting opinions and supporting dialogue directed toward product or trial designs. Simulations and product demos are thoroughly engaging and attract forward-thinking collaborators, and media-rich presentations can foster memorable interactions with meeting attendees. While most of the content discussed in a large-scale medical congress needs to be carefully prepared due to regulatory and compliance requirements, live meetings initiated via social media can offer a less formal and more personal context. Social media channels like Twitter are the best way to organize spontaneous or casual meet-ups, advertise your booth location, or promote the events in which your company is involved.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.